Previous Next


№3' 2021


International Medical Journal, Vol. 27., Iss. 3, 2021, P. 24−29.



Pominchuk D. V., Lashchenko M. V., Lashchenko V. A.

SI "Institute of Pediatrics, Obstetrics and Gynecology named after Acad. O.M Lukyanova, National Academy of Medical Sciences of Ukraine ", Kyiv
Verum Medical Center LLC, Kyiv, Ukraine

Breast cancer is the most common malignancy in women worldwide. The number of cases of breast cancer among young women under 40 is increasing, that requires surgery to not only remove the malignancy, but also to preserve the aesthetic appearance after completion of comprehensive treatment. One of the effective surgical techniques is lipofilling. Real meta−analysis did not show a rise in the recurrence rate in patients who underwent lipofilling after the surgical stage of breast cancer treatment, compared with the group of the patients without this procedure. Lipofilling is an effective method of correction of aesthetic defects, improves the quality of life of patients after the surgical stage of breast cancer treatment. It is important when performing subcutaneous mastectomies with simultaneous endoprosthesis. According to a published reports, lipofilling can be performed in elderly patients. It does not increase the risk of breast cancer in women when performing surgery for aesthetic correction with the absence or presence of benign breast pathology. The lipofilling can influence the choice of surgical method, reduce the need to mobilize large glandular or subcutaneous fat flaps. Patients with affected lymph nodes have an increased risk of developing local and systemic recurrences after the lipofilling procedure. However, there is a number of issues that need to be explored in further research. It is important to study the time period when lipofilling should be performed after the surgical stage of breast cancer treatment, radiation therapy and adjuvant chemotherapy, as the study does not recommend a lipofilling less than 16 months after surgery.

Key words: breast lipofilling, breast cancer, rehabilitation, reconstructive plastic surgery.


1. NCCN Clinical Practise Guidelines in Oncology (NCCN Guidelines) Breast Cancer Version 3. 2020. March 6. URL:

2. Krastev,corresponding author. Metaanalysis of the oncological safety of autologous fat transfer after breast cancer T. K / S. J. Schop et al. // Br. J. Surg. 2018. Vol. 105 (9). P. 1082−1097. doi: 10.1002/bjs.10887

3. Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences / B. G. Kwast Annemiek et al. // Breast Cancer. Res. Treat. 2012. Vol. 135 (1). P. 271−280. doi: 10.1007/s10549−012−2160−z

4. Use of autologous fat grafting for breast reconstruction: a systematic review with meta−analysis of oncological outcomes / R. A. Agha et al. // J. Plast. Reconstryu Aesthet. Surg. 2015. Vol. 68 (2). P. 143−161. doi: 10.1016/j.bjps.2014.10.038

5. Breast cancer and fat grafting: efficacy, safety and complications−a systematic review / M. De Decker et al. // Eur. J. Obstet. Gynecol. Reprod. Biol. 2016. Vol. 207. P. 100−108. doi: 10.1016/j.ejogrb.2016.10.032

6. Fatgrafting for breast cancer patients: from basic science to clinical studies / R. Gennari et al. // Eur. J. Surg. Oncol. 2016. Vol. 42. P. 1088−1102.

7. Autologous fat grafting in onco‐plastic breast reconstruction: a systematic review on oncological and radiological safety, complications, volume retention and patient/surgeon satisfaction / J. W. Groen et al. // J. Plast. Reconstr. Aesthet. Surg. 2016. Vol. 69. P. 742−764. doi:

8. Systematic review: the oncological safety of adipose fat transfer after breast cancer surgery / K. Waked et al. // Breast. 2017. Vol. 31. P. 128−136. doi:

9. Istituti Clinici Scientifici Maugeri Spa − Società Benefit Istituto Europeo di Oncologia Autologous fat transfer after breast cancer surgery: An exact−matching study on the long−term oncological safety / L. Sorrentino et al. // Eur. J. of Surgical Oncology. 2019. Vol. 45. P. 1827−1834. doi:

10. Breast−conserving surgery with immediate autologous fat grafting reconstruction: Oncologic outcomes / J. V. Biazus et al. // Aesthetic Plast. Surg. 2018. Vol. 42 (5). P. 1195−1201. doi: 10.1007/s00266−018−1155−5

11. Lipofilling effects after breast cancer surgery in post−radiation patients: an analysis of results and algorithm proposal / M. Debald et al. // Eur. J. Plast. Surg. 2017. Vol. 40 (5). P. 447−454. doi: 10.1007/s00238−017−1311−1

12. Immediate reconstruction with autologous fat grafting: influence in breast cancer regional recurrence / C. C. Stumpf et al. // Rev. Col. Bras. Cir. 2017. Vol. 44 (2). P. 179−186. doi: 10.1590/0100−69912017002012

13. Breast cancer recurrence is not increased with lipofilling reconstruction: A case−controlled study / C. I. Silva−Vergara et al. // Ann. Plast. Surg. 2017. Vol. 79 (3). P. 243−248. doi:10.1097/SAP. 0000000000001106

14. Oncological outcomes of lipofilling breast reconstruction: 195 consecutive cases and literature review / Claudio Silva−Vergara et al. // J. Plast. Reconstr. Aesthet. Surg. 2016. Vol. 69 (4). P. 475−481. doi: 10.1016/j.bjps.2015.12.029

15. Lipofilling of the breast does not increase the risk of recurrence of breast cancer: A matched controlled study / St. J. Kronowitz et al. // Plast. Reconstr. Surg. 2016. Vol. 137 (2). P. 385−393. doi: 10.1097/01.prs.0000475741.32563.50

16. Fat grafting in breast reconstruction. Retrospective study of satisfaction and quality of life about 68 patients / T. Bayti et al. // Ann. Chir. Plast. Esthet. 2016. Vol. 61 (3). P. 190−199. doi: 10.1016/j.anplas.2015.09.004

17. Evaluation of lipofilling safety in elderly patients with breast cancer / Mario Rietjens et al. // Plast. Reconstr. Surg Glob. Open. 2015. Vol. 3 (7). e441. doi: 10.1097/GOX.0000000000000411

18. Missana M.−C., Germain M. A. Oncologic outcome of 11.6 lipofilling procedures for reconstructive breast surgery // Bull. Acad. Natl. Med. 2014. № 198 (4−5). R. 767−779.

19. Adipose‐derived mesenchymal stem cells (ASCs) may favour breast cancer recurrence via HGF/c‐Met signaling / V. Eterno et al. // Oncotarget. 2014. Vol. 15, № 5 (3). R. 613−633. doi: 10.18632/oncotarget.1359

20. Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose−derived stem cells and breast cancer cells from clinical isolates / L. Zimmerlin et al. // Tissue Eng. Part A. 2011. Vol. 17 (1−2). P. 93−106. doi:

21. Immediate reconstruction with autologous fat transfer following breast−conserving surgery / J. V. Biazus et al. // Clinical Trial Breast J. 2015. Vol. 21 (3). P. 268−275. doi: 10.1111/tbj.12397

22. Procedure, applications, and outcomes of autologous fat grafting / F. Simonacci et al. // Ann. Med. Surg. (Lond.). 2017. Vol. 20. P. 49−60. doi: 10.1016/j.amsu.2017.06.059

23. Characterization and induction of human pre−adipocytes / E. Raposio et al. // Toxicol. In Vitro. 2007. Vol. 21. P. 330−334.

24. In vitro polydeoxyribonucleotide effects on human pre−adipocytes / E. Raposio et al. // Cell Prolif. 2008. Vol. 41. P. 739−754.

25. Adipose−derived stem cells added to platelet−rich plasma for chronic skin ulcer therapy / E. Raposio et al. // Wounds. 2016. Vol. 28. P. 126−131.

26. Differentiation ability of adipose−derived stem cells separated from adipose tissue by a membrane filtration method / A. Higuci et al. // J. Memb. Sci. 2011. Vol. 366. P. 286−294. doi:

27. A comparative study of proliferation and hepatic differentiation of human adipose−derived stem cells / R. Coradeghini et al. // Cells Tissues Organs. 2010. Vol. 191. P. 466−477. doi:

28. Pre−adipocytes commitment to neurogenesis 1: preliminary localisation of cholinergic molecules / M. G. Aluigi et al. // Cell Biol. Int. 2009. Vol. 33. P. 594−601. doi:

29. Neurogenic−committed human pre−adipocytes express CYP1A isoforms / C. Scanarotti et al. // Chem. Biol. Interact. 2010. Vol. 184. P. 474−483. doi:

30. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine / A. J. Salgado, R. L. Reis, N. J. Sousa, J. M. Gimble // Curr. Stem. Cell Res. Ther. 2010. Vol. 5. P. 103−110. doi:

31. A standardized method of isolating adipose−derived stem cells for clinical applications / E. Raposio et al. // Ann. Plast. Surg. 2016. Vol. 76. P. 124−126. doi:

32. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose−derived adult stem cells / G. Rigotti et al. // Plast. Reconstr. Surg. 2007. Vol. 119. P. 1409−1422. doi:

33. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates / K. Yoshimura et al. // J. Cell. Physiol. J. Cell Physiol. 2006. Vol. 208. P. 64−76. doi:

34. Particle size in fat graft retention: a review on the impact of harvesting technique in lipofilling surgical outcomes / T. M. Gause et al. // Adipocyte. 2014. Vol. 3. P. 273−279. doi:

35. Improvement of skin quality after fat grafting: clinical observation and an animal study / A. Mojallal et al. // Plast. Reconstr. Surg. 2009. Vol. 124. P. 765−774.

36. Oncologic safety of fat grafting for autologous breast reconstruction in an animal model of residual breast cancer / M. M. Silva et al. // Plast. Reconstr. Surg. 2019. Vol. 143 (1). P. 103−112. doi: 10.1097/PRS.0000000000005085

37. Bertolini F., Petit J. Y., Kolonin M. G. Stem cells from adipose tissue and breast cancer: hype, risks and hope // Br. J. Cancer. 2015. Vol. 3, № 112 (3). R 419−423. doi: 10.1038/bjc.2014.657

38. Lindegren A., Schultz I., Wickman M. Improved patient−reported outcomes after autologous fat transplantation and corrective surgery after breast surgery // J. Plast. Surg. Hand Surg. 2019. № 53 (2). R. 111−118. doi: 10.1080/2000656X.2018.1561456

39. Basic science review on adipose tissue for clinicians / S. A. Brown et al. // Plast Reconstr. Surg. 2010. Vol. 126 (6). P. 1936−1946. doi: 10.1097/PRS.0b013e3181f44790

Go on Top